Indication
Skin irritation
Skin irritation is a localized, non-immunologic inflammatory reaction of the integumentary system provoked by direct physical, chemical, or environmental disruption of the stratum corneum. Read more about Skin irritation
707 drugs 201 manufacturers
Drugs that treat it
Common Skin irritation therapies.
WHITE PETROLATUM (petrolatum,white)
PEVIDERM (pramoxine HCl)
LIDOCAINE
LIDOCAINE
MOISTUREL (dimethicone)
LIDOCAINE
TOPICAINE 5 (lidocaine)
LIDOCAINE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonSkin irritation is a localized, non-immunologic inflammatory reaction of the integumentary system provoked by direct physical, chemical, or environmental disruption of the stratum corneum.
This condition can affect individuals of any age group, particularly in exposed areas such as the hands, face, or intertriginous skin folds.
Pathophysiologically, disruption of the epidermal barrier triggers innate immune activation and the local release of pro-inflammatory cytokines, causing microvascular dilation and transepidermal water loss.
It is clinically characterized by localized erythema, mild edema, scaling, dryness, and subjective discomfort such as pruritus, stinging, or burning sensations.
- nih.gov
Skin irritation is a localized, non-immunologic inflammatory reaction of the integumentary system provoked by direct physical, chemical, or environmental disruption of the stratum corneum
- fda.gov
Skin irritation is a localized, non-immunologic inflammatory reaction of the integumentary system provoked by direct physical, chemical, or environmental disruption of the stratum corneum Pathophysiologically, disruption of the epidermal barrier triggers innate immune activation and the local release of pro-inflammatory cytokines, causing microvascular dilation and transepidermal water loss
- nih.gov
This condition can affect individuals of any age group, particularly in exposed areas such as the hands, face, or intertriginous skin folds Pathophysiologically, disruption of the epidermal barrier triggers innate immune activation and the local release of pro-inflammatory cytokines, causing microvascular dilation and transepidermal water loss
- nih.gov
This condition can affect individuals of any age group, particularly in exposed areas such as the hands, face, or intertriginous skin folds
- nih.gov
It is clinically characterized by localized erythema, mild edema, scaling, dryness, and subjective discomfort such as pruritus, stinging, or burning sensations
- veedalifesciences.com
It is clinically characterized by localized erythema, mild edema, scaling, dryness, and subjective discomfort such as pruritus, stinging, or burning sensations
Personalize your experience
Follow Skin irritation and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.